3/25
08:17 am
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) had its price target lowered by analysts at HC Wainwright from $4.00 to $2.00. They now have a "neutral" rating on the stock.
Medium
Report
MacroGenics, Inc. (NASDAQ: MGNX) had its price target lowered by analysts at HC Wainwright from $4.00 to $2.00. They now have a "neutral" rating on the stock.
3/21
11:08 pm
mgnx
MacroGenics, Inc. (NASDAQ: MGNX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
Medium
Report
MacroGenics, Inc. (NASDAQ: MGNX) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.
3/20
04:02 pm
mgnx
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results
Medium
Report
MacroGenics Provides Update on Corporate Progress and 2024 Financial Results
3/6
07:30 am
mgnx
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
Medium
Report
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
2/27
07:30 am
mgnx
MacroGenics to Participate in Upcoming Investor Conferences
Medium
Report
MacroGenics to Participate in Upcoming Investor Conferences
2/17
07:32 am
mgnx
The past year for MacroGenics (NASDAQ:MGNX) investors has not been profitable [Yahoo! Finance]
Medium
Report
The past year for MacroGenics (NASDAQ:MGNX) investors has not been profitable [Yahoo! Finance]